XML 99 R78.htm IDEA: XBRL DOCUMENT v3.23.2
Stockholders' Equity (Details 2) - $ / shares
12 Months Ended
May 31, 2023
May 31, 2022
May 31, 2021
Weighted Average Grant-Date Fair Value      
Weighted Average Grant-Date Fair Value, Granted (usd per share)   $ 26.24 $ 10.40
Restricted Stock Units      
Shares      
Non-Vested Stock Award Units Beginning Balance (shares) 670,017    
Non-Vested Stock Award Units, Granted (shares) 379,572    
Non-Vested Stock Award Units, Vested (shares) (275,007)    
Non-Vested Stock Award Units, Cancelled (shares) (38,562)    
Non-Vested Stock Award Units Ending Balance (shares) 736,020 670,017  
Weighted Average Grant-Date Fair Value      
Weighted Average Grant-Date Fair Value Beginning Balance (usd per share) $ 18.36    
Weighted Average Grant-Date Fair Value, Granted (usd per share) 19.99    
Weighted Average Grant-Date Fair Value, Vested (usd per share) 20.29    
Weighted Average Grant-Date Fair Value, Cancelled (usd per share) 19.28    
Weighted Average Grant-Date Fair Value Ending Balance (usd per share) $ 18.36  
Performance Shares      
Shares      
Non-Vested Stock Award Units Beginning Balance (shares) 449,473    
Non-Vested Stock Award Units, Granted (shares) 175,386    
Non-Vested Stock Award Units, Vested (shares) (45,008)    
Non-Vested Stock Award Units, Cancelled (shares) (31,321)    
Non-Vested Stock Award Units Ending Balance (shares) 548,530 449,473  
Weighted Average Grant-Date Fair Value      
Weighted Average Grant-Date Fair Value Beginning Balance (usd per share) $ 17.02    
Weighted Average Grant-Date Fair Value, Granted (usd per share) 21.53    
Weighted Average Grant-Date Fair Value, Vested (usd per share) 20.54    
Weighted Average Grant-Date Fair Value, Cancelled (usd per share) 20.16    
Weighted Average Grant-Date Fair Value Ending Balance (usd per share) $ 19.23 $ 17.02